Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Birmingham Women’s Hospital Leads the Way in Genomic Diagnosis
Wednesday, May 11, 2016
BWH adopts Congenica’s Sapientia for gene-disease insights that reclassify disease.
OGT Launches Cytocell FISH Probes for Glial Tumours
Saturday, May 07, 2016
Company has announced the launch of its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 deletion probe kit for the reliable investigation of glial tumours.
Merck Builds on Leading Viral and Gene Therapy Service Offering
Thursday, May 05, 2016
Merck has announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
High-throughput 96-Well Array for Direct Measurement of DNA Damage
Monday, April 25, 2016
AMSBIO has announced the launch of the 96-Well CometChip® System - a high-throughput platform developed to simultaneously treat and measure DNA damage induced by different treatments, or among different cell types on a single slide using the Comet assay.
Chromatrap Customer Focused Website Goes Live
Tuesday, April 19, 2016
Following extensive customer research, Company has re-designed its website to better serve the needs of end users.
DeNovix Showcases Spectrophotometer / Fluorometer System at AACR
Monday, April 18, 2016
Company will present its DS-11 FX+ Spectrophotometer / Fluorometer at this year’s AACR 2016 meeting in New Orleans, LA.
Horizon Introduces New High Throughput Platform
Friday, April 15, 2016
Company has announced that it has launch of a new platform for immuno-oncology research.
OGT Develops New FISH Probes in ‘Outstanding’ Innovate UK Project
Thursday, April 14, 2016
Cytocell Chromoprobe Multiprobe® non-human FISH probes set to benefit animal husbandry and research.
Robust Microplate for Genomics Sample Preparation
Tuesday, April 12, 2016
Company has announced it will launch an exciting new microplate for genomics sample preparation at the forthcoming Analytica 2016 exhibition in Munich, Germany.
Showing Results 21 - 30 of 2679
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,300+ scientific and medical posters
4,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!